general indications for implementation of GlucoCorticoids therapy in rheumatology
GCs are potent medications discovered in 1949 (Drs. Hench and Kendall won Nobel Prize in 1950) and used since then for various medical indications. In the management of rheumatic disorders, there are two primary indications for their use:
- • Suppression of the inflammatory cascade.
- • Modification of the immune response.